BioSpace News Archive

Business

Skyhawk Therapeutics Partners with Merck to Discover and Develop RNA-Binding Molecules

Skyhawk and Merck will partner to discover and develop innovative RNA-binding small molecules that can form treatments for neurological diseases and cancer.

July 8, 2019
·
2 min read
·
Alex Keown
Business

China’s Pharmaceutical Market Expected to Boom In Coming Years

“I believe the next Google-level company in healthcare could come from China,” stated Jackson Zhu Weiyan, chief executive officer and founder of My Bio-Med. “China is truly embracing innovation.”

July 8, 2019
·
4 min read
·
Mark Terry
Policy

Trump Plans New ‘Favored Nations Clause’ to Tie Drug Prices to the Cost Other Nations Pay

The executive order will demand that drugs purchased by the federal government will not cost more than the lowest price paid by other nations.

July 8, 2019
·
2 min read
·
Alex Keown
Drug Development

Da Volterra Announces Completion of Patient Recruitment for its Phase 2 Clinical Study with DAV132, a Novel Microbiota Protective Therapy

Da Volterra, a clinical-stage biopharmaceutical company developing new therapeutics to protect the intestinal microbiota, announced the completion of patient recruitment for its Phase 2 trial ‘SHIELD’ evaluating DAV132 in patients receiving antibiotics.

July 8, 2019
·
2 min read
Business

Eisai Enters Into Collaboration Research Agreement With University of Dundee on Targeted Protein Degradation Toward Cancer Drug Discovery

Eisai Co.,Ltd. has entered into a collaboration research agreement with the University of Dundee in Scotland, UK, regarding Proteolysis Targeting Chimeras (PROTACs)(1) toward drug discovery in oncology area.

July 8, 2019
·
3 min read
Business

Immatics Appoints Harpreet Singh as Chief Executive Officer

Immatics Biotechnologies GmbH announced that Harpreet Singh has been appointed the Company’s Chief Executive Officer.

July 8, 2019
·
4 min read
Drug Development

New HER-Vaxx Cancer Vaccine trial data presented at the European Society of Medical Oncology World Congress on Gastrointestinal Cancer

Imugene Limited, a clinical stage immuno-oncology company, announced new clinical data from the Phase Ib study of its HER-Vaxx cancer vaccine showing cancer fighting antibody and clinical response rates continue to be positive in the patients receiving the optimal biological dose of vaccine.

July 8, 2019
·
4 min read
PHARMASEAL Launches Second Major Release of EngilityÔ CTMS

PHARMASEAL, a new provider of clinical trial management and governance solutions to enter the market, announces a second major release of its EngilityÔ CTMS platform.

July 8, 2019
·
2 min read
Business

Lung Ambition Alliance launches with goal to double five-year survival in lung cancer by 2025

Collaboration prioritizes scientific innovation and social change to one day eliminate lung cancer as a cause of death

July 8, 2019
·
7 min read
Drug Development

sterna biologicals Strengthens Management Team to Progress Towards Phase IIB Development

sterna biologicals GmbH & Co. KG (sterna) announced that the Company has recently appointed Dr. Marion Wencker as consulting Chief Medical Officer and Dr. Thomas Klaue as consulting Chief Financial Officer.

July 8, 2019
·
3 min read